
Newsletter Subscribe
Enter your email address below and subscribe to our newsletter


Pfizer Inc forecasted that the COVID-19 pandemic would not be behind us until at least 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than expected, potentially delaying authorization.
Pfizer’s Chief Scientific Officer said in a presentation to investors that the company expects some regions to continue to see pandemic levels of COVID-19 cases over the next year or two. Other countries will transition to “endemic” with low, manageable caseloads during that same time period.